Want to join the conversation?
Technology services provider $CSC reported a 1Q17 loss of $21MM or $0.15 per share compared to a profit of $163MM or $1.15 per share last year, due to a rise in restructuring costs as well as higher transaction and integration-related costs. Revenues grew to $1.93Bil from $1.8Bil. Non-GAAP EPS increased to $0.53 from $0.47.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?